We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

28 hedge funds and large institutions have $18.2M invested in Aldeyra Therapeutics in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 21 → 28 (+7)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

39% less capital invested

Capital invested by funds: $30M → $18.2M (-$11.8M)

Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DCM
DAFNA Capital Management
California
+$847K
2
CL
Croft-Leominster
Maryland
+$81.7K
3
FMA
FNY Managed Accounts
New York
+$31.2K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7K
5
UBS Group
UBS Group
Switzerland
+$13K

Top Sellers

1
DM
Deerfield Management
New York
-$1.05M
2
SM
Sabby Management
Florida
-$133K
3
Millennium Management
Millennium Management
New York
-$48K
4
WMSA
Weiss Multi-Strategy Advisers
New York
-$23.2K
5
Morgan Stanley
Morgan Stanley
New York
-$17.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$6.02M – – –
PA
2
Perceptive Advisors
New York
$5.2M – – –
DM
3
Deerfield Management
New York
$1.98M -$1.05M -219,279 -32%
SFM
4
Sphera Funds Management
Israel
$999K – – –
DCM
5
DAFNA Capital Management
California
$738K +$847K +176,232 New
BBA
6
Baker Bros. Advisors
New York
$595K – – –
KCM
7
Knoll Capital Management
Florida
$569K – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$508K +$14.7K +3,067 +3%
Millennium Management
9
Millennium Management
New York
$419K -$48K -9,979 -9%
WMSA
10
Weiss Multi-Strategy Advisers
New York
$298K -$23.2K -4,828 -6%
BC
11
Boxer Capital
California
$265K – – –
PVI
12
Pura Vida Investments
New York
$241K – – –
SM
13
Sabby Management
Florida
$172K -$133K -27,603 -40%
CL
14
Croft-Leominster
Maryland
$71K +$81.7K +17,000 New
Northern Trust
15
Northern Trust
Illinois
$51K – – –
FMA
16
FNY Managed Accounts
New York
$27.2K +$31.2K +6,502 New
Morgan Stanley
17
Morgan Stanley
New York
$15K -$17.5K -3,633 -50%
BA
18
BlackRock Advisors
Delaware
$12K – – –
UBS Group
19
UBS Group
Switzerland
$12K +$13K +2,715 +3,935%
VIA
20
Vantage Investment Advisors
Pennsylvania
$8K – – –
Bank of America
21
Bank of America
North Carolina
$8K +$9.61K +2,000 New
BIM
22
BlackRock Investment Management
Delaware
$4K – – –
BFA
23
BlackRock Fund Advisors
California
$4K +$1.1K +228 +29%
Manulife (Manufacturers Life Insurance)
24
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K +$4.52K +941 New
TRCT
25
Tower Research Capital (TRC)
New York
$3K +$2.31K +480 +308%
1
2

ALDX Hedge Fund Activity: Q1 2016 in Review

28 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q1 2016, worth a combined $18.2M — down 39% from $30M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ALDX positions and 0 closed out — a net gain of 7 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $847K. The largest seller was Deerfield Management, cutting an estimated $1.05M.

  • 28 institutional investors held Aldeyra Therapeutics (ALDX) as of Q1 2016, up from 21 in Q4 2015.
  • Funds reported $18.2M of Aldeyra Therapeutics stock for Q1 2016, down 39% quarter-over-quarter.
  • 7 funds opened new Aldeyra Therapeutics positions in Q1 2016 and 0 closed out, a net change of +7 holders.
  • The largest Aldeyra Therapeutics buyer in Q1 2016 was DAFNA Capital Management, an estimated $847K added.
  • The largest Aldeyra Therapeutics seller in Q1 2016 was Deerfield Management, an estimated $1.05M sold.

Based on aggregated 13F filings for Q1 2016.